AVANIR PHARMACEUTICALS INC's ticker is AVNR and the CUSIP is 05348P401. A total of 108 filers reported holding AVANIR PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is 1.25 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $8,475,000 | -76.3% | 500,000 | -83.3% | 0.30% | -77.4% |
| Q3 2014 | $35,760,000 | +111.3% | 3,000,000 | 0.0% | 1.32% | +92.4% |
| Q2 2014 | $16,920,000 | +109.6% | 3,000,000 | +36.4% | 0.68% | +133.4% |
| Q1 2014 | $8,074,000 | -22.5% | 2,200,000 | -29.0% | 0.29% | -21.7% |
| Q4 2013 | $10,416,000 | -27.6% | 3,100,000 | -8.8% | 0.37% | -20.1% |
| Q3 2013 | $14,382,000 | -11.9% | 3,400,000 | -4.2% | 0.47% | -8.9% |
| Q2 2013 | $16,330,000 | – | 3,550,000 | – | 0.51% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 2,436,053 | $10,329,000 | 1.78% |
| GREAT POINT PARTNERS LLC | 200,000 | $846,000 | 0.59% |
| Tekla Capital Management LLC | 960,000 | $4,070,000 | 0.45% |
| Artal Group S.A. | 3,100,000 | $13,113,000 | 0.43% |
| Baker Brothers Advisors | 4,428,591 | $18,733,000 | 0.27% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1,446,839 | $6,120,000 | 0.24% |
| FORTALEZA ASSET MANAGEMENT INC/ | 96,545 | $408,000 | 0.21% |
| EAM Investors, LLC | 236,609 | $1,003,000 | 0.20% |
| ASCEND CAPITAL, LLC | 979,370 | $4,143,000 | 0.15% |
| Orbimed Advisors | 1,863,400 | $7,882,000 | 0.14% |